These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12943677)

  • 1. The genetic background as a determinant of human T-cell leukemia virus type 1 proviral load.
    Nitta T; Tanaka M; Sun B; Hanai S; Miwa M
    Biochem Biophys Res Commun; 2003 Sep; 309(1):161-5. PubMed ID: 12943677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers.
    Mori S; Mizoguchi A; Kawabata M; Fukunaga H; Usuku K; Maruyama I; Osame M
    Thorax; 2005 Feb; 60(2):138-43. PubMed ID: 15681503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
    Rego FF; de Oliveira T; Giovanetti M; Galvão-Castro B; Gonçalves Mde S; Alcantara LC
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):279-83. PubMed ID: 26472535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.
    Lee TH; Chafets DM; Busch MP; Murphy EL
    J Clin Virol; 2004 Dec; 31(4):275-82. PubMed ID: 15494269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Montanheiro PA; Oliveira AC; Posada-Vergara MP; Milagres AC; Tauil C; Marchiori PE; Duarte AJ; Casseb J
    Braz J Med Biol Res; 2005 Nov; 38(11):1643-7. PubMed ID: 16258633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study.
    Kuramitsu M; Okuma K; Yamochi T; Sato T; Sasaki D; Hasegawa H; Umeki K; Kubota R; Sobata R; Matsumoto C; Kaneko N; Naruse I; Yamagishi M; Nakashima M; Momose H; Araki K; Mizukami T; Mizusawa S; Okada Y; Ochiai M; Utsunomiya A; Koh KR; Ogata M; Nosaka K; Uchimaru K; Iwanaga M; Sagara Y; Yamano Y; Satake M; Okayama A; Mochizuki M; Izumo S; Saito S; Itabashi K; Kamihira S; Yamaguchi K; Watanabe T; Hamaguchi I
    J Clin Microbiol; 2015 Nov; 53(11):3485-91. PubMed ID: 26292315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
    Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.
    Adaui V; Verdonck K; Best I; González E; Tipismana M; Arévalo J; Vanham G; Campos M; Zimic M; Gotuzzo E
    J Neurovirol; 2006 Dec; 12(6):456-65. PubMed ID: 17162661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
    Furtado Mdos S; Andrade RG; Romanelli LC; Ribeiro MA; Ribas JG; Torres EB; Barbosa-Stancioli EF; Proietti AB; Martins ML
    J Med Virol; 2012 Apr; 84(4):664-71. PubMed ID: 22337307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
    Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
    Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats.
    Ishiguro N; Abe M; Seto K; Sakurai H; Ikeda H; Wakisaka A; Togashi T; Tateno M; Yoshiki T
    J Exp Med; 1992 Oct; 176(4):981-9. PubMed ID: 1402668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Starling AL; Martins-Filho OA; Lambertucci JR; Labanca L; de Souza Pereira SR; Teixeira-Carvalho A; Martins ML; Ribas JG; Carneiro-Proietti AB; Gonçalves DU
    Acta Trop; 2013 Jan; 125(1):75-81. PubMed ID: 23022356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
    Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
    J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.
    Vine AM; Heaps AG; Kaftantzi L; Mosley A; Asquith B; Witkover A; Thompson G; Saito M; Goon PK; Carr L; Martinez-Murillo F; Taylor GP; Bangham CR
    J Immunol; 2004 Oct; 173(8):5121-9. PubMed ID: 15470056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
    Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
    J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral health profile in patients infected with HTLV-1: clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva.
    Lins L; de Carvalho VJ; de Almeida Rego FF; Azevedo R; Kashima S; Gallazi VN; Xavier MT; Galvão-Castro B; Alcantara LC
    J Med Virol; 2012 Sep; 84(9):1428-36. PubMed ID: 22825822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phylogenetic classification of human T cell leukaemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes.
    Vidal AU; Gessain A; Yoshida M; Tekaia F; Garin B; Guillemain B; Schulz T; Farid R; De Thé G
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3655-66. PubMed ID: 7996161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.